February 16, 2024

Salk Professor Janelle Ayres elected to American Academy of Microbiology

Salk News


Salk Professor Janelle Ayres elected to American Academy of Microbiology

LA JOLLA—Salk Institute Professor Janelle Ayres has been elected to the American Academy of Microbiology’s Fellowship Class of 2024. Fellows of the Academy, an honorific leadership group within the American Society for Microbiology, are elected annually through a highly selective, peer-review process based on their records of scientific achievement and original contributions that have advanced microbiology. The Academy received 156 nominations this year, electing 65 into the 2024 Fellowship Class.

Janelle Ayres
Janelle Ayres
Click here for a high-resolution image.
Credit: Salk Institute

“On behalf of all our colleagues here at Salk, I want to extend our warm congratulations to Janelle for her exceptional scientific achievements and for this prestigious recognition,” says Salk President Gerald Joyce. “Her passion, creativity, and relentless pursuit of knowledge exemplify the spirit of excellence we strive for at Salk. We are grateful for the impact she continues to make in advancing high-impact science."

Ayres is head of the Molecular and Systems Physiology Laboratory, a member of both the Gene Expression Laboratory and the NOMIS Center for Immunobiology and Microbial Pathogenesis, and holder of the Salk Institute Legacy Chair. Her track record of achievements also includes an NIH Director’s Pioneer Award and the Blavatnik National Award for Young Scientists.

Ayres’ research upends our understanding of how to survive disease. The longstanding assumption for biomedical researchers is that health is the absence of disease and that to be healthy, one must simply remove the primary source of the disease. In contrast, through her pioneering work on host-pathogen interactions, Ayres has demonstrated that health is an active process involving evolved physiological defense mechanisms, creating a new paradigm and field that she calls “the biology of health.” At its core is Ayres’ discovery of the “Cooperative Defense System,” which has challenged the notion that, in order to survive infections, the host needs to kill the pathogen. The Cooperative Defense System encodes disease-tolerance mechanisms that promote health and survival by providing a physiological defense, without killing the pathogen. The discoveries made by Ayres and her research team have obvious therapeutic implications for infectious diseases, with the potential to extend to non-infectious diseases.

“Academy Fellowship signifies a distinguished accolade, and I am delighted to extend my congratulations and warm welcome to Dr. Ayres as a member of the 2024 Cohort,” says Vanessa Sperandio, chair of the Academy Governors. “Fellows are an outstanding assembly of scientists whose contributions have propelled discipline and whose knowledge benefits both the scientific community and broader society.”

The American Society for Microbiology is one of the largest professional societies dedicated to the life sciences and is composed of 36,000 scientists and health practitioners. Their mission is to promote and advance the microbial sciences. The society advances the microbial sciences through conferences, publications, certifications, educational opportunities, and advocacy efforts. It enhances laboratory capacity around the globe through training and resources. It provides a network for scientists in academia, industry, and clinical settings. Additionally, the American Society for Microbiology promotes a deeper understanding of the microbial sciences to diverse audiences.

Research Areas

For More Information

Office of Communications
Tel: (858) 453-4100
press@salk.edu

The Salk Institute For Biological Studies:

Unlocking the secrets of life itself is the driving force behind the Salk Institute. Our team of world-class, award-winning scientists pushes the boundaries of knowledge in areas such as neuroscience, cancer research, aging, immunobiology, plant biology, computational biology and more. Founded by Jonas Salk, developer of the first safe and effective polio vaccine, the Institute is an independent, nonprofit research organization and architectural landmark: small by choice, intimate by nature, and fearless in the face of any challenge.